TNGX - Latest News
Tango Therapeutics, Inc. (TNGX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $2.96B. Beta to the broader market is 1.22.
The article list below shows the most recent TNGX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent TNGX Headlines
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
globenewswire.com - May 13, 2026
First clinical data from PRMT5/RAS(ON) combination trial to be pre sented in 2026 Cash position of $380 million as of March 31, 2026, with runway into
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - May 4, 2026
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that effective May 1, 2026, the Compensation Commit
Massachusetts Financial Services Co. MA Acquires New Shares in Tango Therapeutics, Inc. $TNGX
defenseworld.net - Apr 19, 2026
Massachusetts Financial Services Co. MA acquired a new stake in Tango Therapeutics, Inc.
Insider Selling: Tango Therapeutics (NASDAQ:TNGX) Insider Sells $961,500.00 in Stock
defenseworld.net - Apr 19, 2026
Tango Therapeutics, Inc. (NASDAQ: TNGX - Get Free Report) insider Adam Crystal sold 38,460 shares of Tango Therapeutics stock in a transaction on Wed
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
globenewswire.com - Apr 15, 2026
- Matthew Gall appointed Chief Financial Officer - - Additional key appointments add expertise in clinical operations, corporate strategy and proje
How News Affects TNGX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track TNGX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked TNGX news questions
- What is the latest TNGX news headline?
- The most recent TNGX headline (May 13, 2026) is "Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the TNGX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What TNGX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual TNGX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.